Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-27 · accession 0001161662-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-02 | 2026-02-27 | JAZZ | RIEDEL NORBERT G | Dir | M - OptEx | $138.08 | +3,415 | 10.4K | +49% | +$471.5K |
| D | 2026-03-02 | 2026-02-27 | JAZZ | RIEDEL NORBERT G | Dir | S - Sale+OE | $192.00 | -3,415 | 7,024 | -33% | -$655.7K |
| D | 2026-03-02 | 2026-02-27 | JAZZ | RIEDEL NORBERT G | Dir | M - OptEx | $0.00 | -3,415 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-02-27 | M | A | 3,415 | $138.08 | 10,439 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-02-27 | S | D | 3,415 | $192.00 | 7,024 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-02-27 | M | D | 3,415 | $0.00 | 0 | D | $138.08 · — to 2026-08-10 | 3,415 Ordinary Shares | (F1) This non-qualified stock option was granted on August 11, 2016 and vested over a period of one year from September 1, 2016. The options were fully vested as of August 1, 2017. |